|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 48, 2463-2470, November 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology
Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892
Published, JLR Papers in Press, August 22, 2007.
1 To whom correspondence should be addressed. e-mail: mikii{at}mail.nih.gov
Fifteen weeks of dietary n-3 PUFA deprivation increases coefficients of conversion of circulating
-linolenic acid (
-LNA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) in rat liver but not brain. To determine whether these increases reflect organ differences in enzymatic activities, we examined brain and liver expression of converting enzymes and of two of their transcription factors, peroxisome proliferator-activated receptor
(PPAR
) and sterol-regulatory element binding protein-1 (SREBP-1), in rats fed an n-3 PUFA "adequate" (4.6%
-LNA of total fatty acid, no DHA) or "deficient" (0.2%
-LNA, no DHA) diet for 15 weeks after weaning. In rats fed the deficient compared with the adequate diet, mRNA and activity levels of
5 and
6 desaturases and elongases 2 and 5 were upregulated in liver but not brain, but liver PPAR
and SREBP-1 mRNA levels were unchanged. In rats fed the adequate diet, enzyme activities generally were higher in liver than brain. Thus, differences in conversion enzyme expression explain why the liver has a greater capacity to synthesize DHA from circulating
-LNA than does the brain in animals on an adequate n-3 PUFA diet and why liver synthesis capacity is increased by dietary deprivation. These data suggest that liver n-3 PUFA metabolism determines DHA availability to the brain when DHA is absent from the diet.
Supplementary key words ß-oxidation diet docosahexaenoic acid
-linolenic acid polyunsaturated fatty acid
Abbreviations: AA, arachidonic acid (20:4n-6); CPT-1, carnitine palmitoyltransferase-1; DHA, docosahexaenoic acid (22:6n-3); DPA, docosapentaenoic acid (22:5n-6); DTA, docosatetraenoic acid (22:4n-6); EPA, eicosapentaenoic acid (20:5n-3); FAME, fatty acid methyl ester; KPB, potassium phosphate buffer; LA, linoleic acid (18:2n-6);
-LNA,
-linolenic acid (18:3n-3); PPAR, peroxisome proliferator-activated receptor; PUFA, polyunsaturated fatty acid; SREBP, sterol-regulatory element binding protein
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Igarashi, K. Ma, L. Chang, J. M. Bell, and S. I. Rapoport Rat heart cannot synthesize docosahexaenoic acid from circulating {alpha}-linolenic acid because it lacks elongase-2 J. Lipid Res., August 1, 2008; 49(8): 1735 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Green, S. K. Orr, and R. P. Bazinet The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids J. Lipid Res., May 1, 2008; 49(5): 939 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Chen, D. W. L. Ma, J. H. Kim, H. T. J. Mount, and R. P. Bazinet The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations J. Lipid Res., January 1, 2008; 49(1): 147 - 152. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |